SHIELD t3

SHIELD T3 is an organization created by the University of Illinois System as a way to expand the testing of saliva-based COVID-19 that was pioneered by the University of Illinois researchers. SHIELD T3 is working on marketing the innovative COVID-19 testing technology nationwide to encourage widespread testing that produces rapid results in order to limit the spread of COVID-19.
BOARD OF MANAGERS EXECUTIVE COMMITTEE
-
Bill Jackson, Principal Officer of Shield T3
-
Donald D. Edwards, Chair
-
Michael Tokarz, Vice Chair
-
Dr. Andreas C. Cangellaris
MEETING NOTICES
UPCOMING MEETING DATES/LOCATIONS
SHIELD T3 Board of Managers meets at least twice a year. Special meetings may be called as needed by the Board of Managers. The Executive Committee is also meeting on a regular basis.
Wednesday, August 19th, 2020, 11:00 AM
Meeting Agenda Meeting Notes
Monday, September 28th, 2020, 3:00 PM
Meeting Agenda Meeting Notes
Thursday, October 15th, 2020, 11:00 AM
Meeting Agenda Meeting Notes
Thursday, October 22nd, 2020, 11:00 AM
Meeting Agenda Meeting Notes
Friday, October 30th, 2020 10:00 AM
Meeting Agenda Meeting Notes
Thursday, November 5th, 2020, 11:00 AM
Meeting Agenda Meeting Notes
Thursday, November 19th, 2020, 11:00 AM
Meeting Agenda Meeting Notes
Thursday, December 3, 2020, 11:00 am
Board of Managers Executive Committee Meeting
Meeting Agenda Meeting Notes
Thursday, December 10, 2020, 11:00 am
Board of Managers Executive Committee Meeting
Meeting Agenda
Thursday, December 17, 2020, 11:00 am:
Board of Managers Executive Committee Meeting
Meeting Agenda
Thursday, January 7, 2021, 11:00 am Zoom Meeting
Board of Managers Executive Committee Meeting
Meeting Agenda